You may not be able to control every menstrual fluctuation, but you can support your body through the transition period
Glucagon-like peptide-1 receptor agonists, or GLP-1 agonists , are a class of drugs that started as a diabetes treatment and then evolved into a popular weight loss tool
While the insurers approximately $3 billion in reserves can help absorb such losses, three consecutive years of such huge numbers amount to a meaningful hit
As Habener explains, 'Previous studies in animals had shown that GLP-1 slowed down acid secretion and stomach emptying and caused early satiety
These include: Nausea (the most frequently reported adverse effect) Vomiting Diarrhoea Constipation Decreased appetite (which, while contributing to weight loss, can occasionally be excessive) These effects were generally mild to moderate in severity and occurred most frequently during the dose-escalation phase
It represents a fundamentally different pharmacological strategy, one that early clinical data suggests could nearly double the weight loss seen with semaglutide while simultaneously delivering dramatic improvements in liver fat, metabolic markers, and body composition